Skip to content

The Offer of Neurosurgery Care in the Grand Est of France During the Health Crisis Linked to Covid-19

The Offer of Neurosurgery Care in the Grand Est of France During the Health Crisis Linked to Covid-19

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04701905
Acronym
NeurochirCOVID
Enrollment
450
Registered
2021-01-08
Start date
2020-04-30
Completion date
2021-04-30
Last updated
2021-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19 Pandemic

Keywords

COVID-19 Pandemic, Coronavirus, Sars-cov-2

Brief summary

During this exceptional health crisis, this study of the current care of a neurosurgical activity, which is essential in a University Hospital Centre, will enable us to better understand how we function, the response given to a population with the means at our disposal, the implementation of new therapeutic strategies and their limits, ethical reflection, and, how to pursue a distributive and quality medicine. The restriction of conventional medical resources to our care activity (resuscitation, personnel, operating theatre, constraints linked to the risk of contamination...) is leading to a new medical organisation imposing new Covid-19 standards, the description of which seems essential to us. A knowledge of the strategies to be adopted during a disaster health situation in order to continue providing care to the civilian population. How can we prevent the setting up of health care systems outside the cause of the health crisis? n triage medicine, Avoiding the burn-out of doctors struck by the health crisis.

Interventions

None listed

Sponsors

University Hospital, Strasbourg, France
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient aged over 18; * Entering the neurosurgery care sector requiring support between 03/16/2020 and 06/15/2020; * Having not expressed his opposition, after information, to the reuse of his data for the purposes of this research.

Exclusion criteria

* Subject having expressed opposition to participating in the study * Subject under guardianship or guardianship * Subject under safeguard of justice

Design outcomes

Primary

MeasureTime frame
Retrospective analysis of the management of neurosurgical pathologies in a health crisis situation of the Covid-19 pandemicThe files analysed retrospectily from March 16, 2020 to June 15, 2020 will be examined]

Countries

France

Contacts

Primary ContactFrançois PROUST, MD, PhD
francois.proust@chru-strasbourg.fr33 3 88 12 76 12
Backup ContactSaïd CHAYER, PhD, HDR
said.chayer@chru-strasbourg.fr33 3 88 11 66 90

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026